VT
TEVA icon

Vise Technologies’s Teva Pharmaceuticals TEVA Stock Holding History

Vise Technologies’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
39,384
+18,354
+87% +$611K 0.02% 671
2026
Q1 		$656K Hold
21,030
– – 0.01% 748
2025
Q4 		$656K Buy
21,030
+1,700
+9% +$41.9K 0.01% 753
2025
Q3 		$390K Sell
19,330
-144
-0.7% -$2.53K 0.01% 786
2025
Q2 		$326K Buy
+19,474
New +$314K 0.01% 813
2024
Q4 		$293K Buy
+13,287
New +$242K 0.02% 604

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Vise Technologies's TEVA Position: Q2 2026 in Review

Vise Technologies increased its Teva Pharmaceuticals (TEVA) stake by 87% in Q2 2026, buying an estimated $611K and bringing the position to 39,384 shares worth $1.33M. The position accounts for 0.02% of the portfolio, ranked #671.

Vise Technologies first reported a position in TEVA in Q4 2024 and has held it in 6 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Vise Technologies held 39,384 shares of Teva Pharmaceuticals worth $1.33M as of Q2 2026.
  • Vise Technologies bought 18,354 Teva Pharmaceuticals shares in Q2 2026, an estimated $611K.
  • Teva Pharmaceuticals made up 0.02% of Vise Technologies's portfolio in Q2 2026, its #671 holding.
  • Vise Technologies first reported a position in Teva Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.